Alternatives to the use of estrogen in postmenopausal women.
Pinkerton
J V
JV
Department of Obstetrics/Gynecology, Women's Place and the Cancer Center, University of Virginia Health Sciences Center, Charlottesville 22903-9301, USA. JVP9U@HSCMAIL.mcc.virginia.edu
Santen
R
R
D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control*; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology; D000075202:Contraindications; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control; D017698:Postmenopause / Q000187:drug effects* / Q000502:physiology; D014566:Urogenital System / Q000187:drug effects / Q000502:physiology; D014666:Vasomotor System / Q000187:drug effects / Q000502:physiology
D004965:Estrogen Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors